Product Information
FLUTICASONE-VILANTEROL 100-25 is a generic product labeled by Prasco Laboratories, priced at $3.8971 per EA under NDC 66993013597. Its NADAC has been published 216 times since Aug 17, 2022.
FDA first approved this application on May 10, 2013.
Strength
100; 25 ug/1; ug/1
Manufacturer
Prasco LaboratoriesNDC
66993013597
Classification
Generic
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE FUROATE; VILANTEROL TRIFENATATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204275FDA Approved
5/10/2013
On Market Since
5/23/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE-VILANTEROL 100-25 has been published 216 times since Aug 17, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.8971 per EA |
|---|---|
| All-time high | $4.0148 (Dec 14, 2022) |
| All-time low | $3.6241 (Jul 17, 2024) |
| 52-week high | $3.8971 |
| 52-week low | $3.8241 |
| Median price | $3.8305 |
| Average price | $3.8187 |
| Largest weekly change | -6.5% (Nov 20, 2024) |
| Weeks tracked | 216 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone furoate and vilanterol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone furoate and vilanterol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE-VILANTEROL 100-25?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-VILANTEROL 100-25, manufactured by Prasco Laboratories, is $3.8971 per EA (NDC 66993013597), effective Sep 30, 2026.
How has the price of FLUTICASONE-VILANTEROL 100-25 changed over time?
Over the history we have for it, the NADAC for FLUTICASONE-VILANTEROL 100-25 has held within roughly two percent of its current level. It has been tracked across 216 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for FLUTICASONE-VILANTEROL 100-25?
Since Aug 17, 2022, the NADAC for FLUTICASONE-VILANTEROL 100-25 has ranged from a low of $3.6241 (Jul 17, 2024) to a high of $4.0148 (Dec 14, 2022), with a median of $3.8305 per EA.
Are there cheaper alternatives to FLUTICASONE-VILANTEROL 100-25?
No other NADAC-published product currently shares the active ingredient and strength of FLUTICASONE-VILANTEROL 100-25 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUTICASONE-VILANTEROL 100-25?
FLUTICASONE-VILANTEROL 100-25 (NDC 66993013597) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.